Page last updated: 2024-08-24

nafagrel and Proteinuria

nafagrel has been researched along with Proteinuria in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagamatsu, T; Nagao, T; Suzuki, Y2
Ito, M; Nagamatsu, T; Nagao, T; Suzuki, Y1
Abe, Y; Ashida, S; Irie, K; Kunitada, S; Masumura, H1

Other Studies

4 other study(ies) available for nafagrel and Proteinuria

ArticleYear
Effect of DP-1904, a thromboxane A2 synthase inhibitor, administered from the autologous phase on crescentic-type anti-GBM nephritis in rats.
    Japanese journal of pharmacology, 1995, Volume: 68, Issue:2

    Topics: Animals; Antimetabolites; Azathioprine; Creatinine; Enzyme Inhibitors; gamma-Globulins; Glomerulonephritis; Imidazoles; Immunoenzyme Techniques; Male; Methacrylates; Proteinuria; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Thromboxane-A Synthase

1995
Effect of DP-1904, a thromboxane A2 synthetase inhibitor, on crescentic nephritis in rats.
    European journal of pharmacology, 1994, Jul-11, Volume: 259, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Basement Membrane; Cholesterol; Dinoprostone; Fluorescent Antibody Technique; Imidazoles; Kidney Glomerulus; Male; Methacrylates; Nephritis, Interstitial; Platelet Aggregation; Proteinuria; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1994
Effect of DP-1904, a thromboxane A2 synthase inhibitor, on passive Heymann nephritis in rats.
    European journal of pharmacology, 1996, Nov-28, Volume: 316, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antibodies; Azathioprine; Creatinine; Dinoprostone; Drug Interactions; Enzyme Inhibitors; Glomerulonephritis; Imidazoles; Immunoglobulin G; Immunosuppressive Agents; Kidney Glomerulus; Male; Methacrylates; Proteinuria; Rabbits; Rats; Rats, Sprague-Dawley; Renal Circulation; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1996
A thromboxane A2 synthetase inhibitor retards hypertensive rat diabetic nephropathy.
    European journal of pharmacology, 1992, Jan-14, Volume: 210, Issue:2

    Topics: Acetylglucosaminidase; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephropathies; gamma-Glutamyltransferase; Heart Rate; Hypertension; Imidazoles; Kidney; Prostaglandins; Proteinuria; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase

1992